Boundless GPCR drug discovery
Design Pharmaceuticals applies robust ultra-high throughput bioscience technologies in a novel approach to dramatically accelerate GPCR drug discovery and outpace current industry capabilities. Our goal is to enable new treatments for patients suffering from diseases for which there are no satisfactory therapies.
We use novel technologies to unlock and deorphanize GPCR drug targets with unrivaled deep exploration of the drug space
Mapping the GPCR Interactome at scale to enable drug discovery and development
|
Small Molecules |
|
Antibodies / Nanobodies |
|
Peptides / Hormones |
|
Cell based Agonist |
|
Cell based Antagonist |
|
Droplet 10^8 / week Single GPCR |
|
Automated 10^4 / week Multiplex |
Our multiplex GPCR platform allows scalable and flexible interrogation of GPCR signaling for drug development
Multiplexing GPCRs readouts powers data generation for computational and experimental drug design
Unprecedented scale allows powerful data generation to develop drugs understanding via design, build, test, learn cycles
We are developing the future of GPCR screening by enabling live cell functional screening in millions of parallel droplets incubators
We collaborate with your research and development teams on discovery projects and joint research programs to develop breakthrough therapeutics for GPCR drug targets. Our unmatched technologies benefit discovery programs by screening the largest complex libraries for hit candidates based on drug function. We screen all types of ligand libraries in multiple GPCR assay formats at unprecedented scale and speed, delivering high-quality data with industry-leading throughput.
Contact Us
Send us a message and we will get back to you as soon as possible.